LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 73 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $229,000 | -9.8% | 26,021 | -5.3% | 0.05% | -14.8% |
| Q2 2019 | $254,000 | +13.4% | 27,470 | +15.4% | 0.05% | +42.1% |
| Q4 2018 | $224,000 | -27.0% | 23,806 | +56.0% | 0.04% | +18.8% |
| Q3 2018 | $307,000 | -59.8% | 15,261 | -41.7% | 0.03% | -95.3% |
| Q2 2018 | $764,000 | -17.7% | 26,180 | -16.0% | 0.68% | -16.1% |
| Q1 2018 | $928,000 | +100.4% | 31,173 | +116.6% | 0.80% | +38.6% |
| Q4 2017 | $463,000 | +12.4% | 14,394 | +21.5% | 0.58% | +937.5% |
| Q3 2017 | $412,000 | +28.8% | 11,845 | +10.1% | 0.06% | +16.7% |
| Q2 2017 | $320,000 | -32.3% | 10,761 | -32.1% | 0.05% | -42.9% |
| Q1 2017 | $473,000 | +88.4% | 15,848 | +10.6% | 0.08% | +12.0% |
| Q4 2016 | $251,000 | -26.2% | 14,329 | +0.3% | 0.08% | -54.3% |
| Q3 2016 | $340,000 | +48.5% | 14,291 | 0.0% | 0.16% | -3.5% |
| Q2 2016 | $229,000 | +13.4% | 14,291 | +48.2% | 0.17% | -38.8% |
| Q1 2016 | $202,000 | -27.1% | 9,645 | -5.9% | 0.28% | -63.4% |
| Q4 2015 | $277,000 | – | 10,250 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |